Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-272375
Filing Date
2025-11-07
Accepted
2025-11-07 16:15:06
Documents
78
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rkda-20250930.htm   iXBRL 10-Q 2783795
2 EX-31.1 rkda-ex31_1.htm EX-31.1 14878
3 EX-31.2 rkda-ex31_2.htm EX-31.2 14872
4 EX-32.1 rkda-ex32_1.htm EX-32.1 9862
5 EX-32.2 rkda-ex32_2.htm EX-32.2 9636
  Complete submission text file 0001193125-25-272375.txt   11863693

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250930.xsd EX-101.SCH 1593429
81 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250930_htm.xml XML 2487721
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37383 | Film No.: 251462833
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)